Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

NCT: NCT03523416 · RECRUITING

NCT IDNCT03523416
StatusRECRUITING
Start Date2018-07-31
Completion2032-04
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards APTURE transcatheter shunt system.

Frequently Asked Questions

What is Early Feasibility Study - Edwards APTURE Transcatheter Shunt System?

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System is a clinical trial registered under NCT03523416. Current status: RECRUITING.

What is the status of NCT03523416?

The current status of NCT03523416 (Early Feasibility Study - Edwards APTURE Transcatheter Shunt System) is: RECRUITING.

When did Early Feasibility Study - Edwards APTURE Transcatheter Shunt System start?

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System started on 2018-07-31.

Related Devices

K152980Flo Trac sensor, Volume View sensorEdwards Lifesciences, LLC K153069Edwards Balloon CatheterEdwards Lifesciences K160084Swan Ganz CathetersEdwards Lifesciences, LLC K160552EV1000 Clinical Platform with ClearSight Finger Cuff or ClearSight System, EV1000 Clinical PlatformEdwards Lifesciences, LLC K160645PreSep Oligon Oximetry CatheterEdwards Lifesciences, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑